257 related articles for article (PubMed ID: 33568479)
1. Mechanisms of stearoyl CoA desaturase inhibitor sensitivity and acquired resistance in cancer.
Oatman N; Dasgupta N; Arora P; Choi K; Gawali MV; Gupta N; Parameswaran S; Salomone J; Reisz JA; Lawler S; Furnari F; Brennan C; Wu J; Sallans L; Gudelsky G; Desai P; Gebelein B; Weirauch MT; D'Alessandro A; Komurov K; Dasgupta B
Sci Adv; 2021 Feb; 7(7):. PubMed ID: 33568479
[TBL] [Abstract][Full Text] [Related]
2. Critical role of miR-125b in lipogenesis by targeting stearoyl-CoA desaturase-1 (SCD-1).
Cheng X; Xi QY; Wei S; Wu D; Ye RS; Chen T; Qi QE; Jiang QY; Wang SB; Wang LN; Zhu XT; Zhang YL
J Anim Sci; 2016 Jan; 94(1):65-76. PubMed ID: 26812313
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and physiological function of stearoyl-CoA desaturase.
Paton CM; Ntambi JM
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E28-37. PubMed ID: 19066317
[TBL] [Abstract][Full Text] [Related]
4. Protein engineering: Regulatory perspectives of stearoyl CoA desaturase.
Kamal S; Saleem A; Rehman S; Bibi I; Iqbal HMN
Int J Biol Macromol; 2018 Jul; 114():692-699. PubMed ID: 29605251
[TBL] [Abstract][Full Text] [Related]
5. Stearoyl-CoA desaturase activity modulates the activation of epidermal growth factor receptor in human lung cancer cells.
Nashed M; Chisholm JW; Igal RA
Exp Biol Med (Maywood); 2012 Sep; 237(9):1007-17. PubMed ID: 22946088
[TBL] [Abstract][Full Text] [Related]
6. Stearoyl-CoA Desaturase-1 Attenuates the High Shear Force Damage Effect on Human MG63 Osteosarcoma Cells.
Huang KC; Chuang PY; Hsieh RZ; Chen CN; Chang SF; Su YP
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630668
[TBL] [Abstract][Full Text] [Related]
7. Stearoyl-CoA desaturase plays an important role in proliferation and chemoresistance in human hepatocellular carcinoma.
Bansal S; Berk M; Alkhouri N; Partrick DA; Fung JJ; Feldstein A
J Surg Res; 2014 Jan; 186(1):29-38. PubMed ID: 24135379
[TBL] [Abstract][Full Text] [Related]
8. Adipose tissue stearoyl-CoA desaturase 1 index is increased and linoleic acid is decreased in obesity-prone rats fed a high-fat diet.
Cedernaes J; Alsiö J; Västermark A; Risérus U; Schiöth HB
Lipids Health Dis; 2013 Jan; 12():2. PubMed ID: 23298201
[TBL] [Abstract][Full Text] [Related]
9. Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol.
Ntambi JM
J Lipid Res; 1999 Sep; 40(9):1549-58. PubMed ID: 10484602
[TBL] [Abstract][Full Text] [Related]
10. Stearoyl-CoA desaturase: a vital checkpoint in the development and progression of obesity.
Poudyal H; Brown L
Endocr Metab Immune Disord Drug Targets; 2011 Sep; 11(3):217-31. PubMed ID: 21831035
[TBL] [Abstract][Full Text] [Related]
11. Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy.
Roongta UV; Pabalan JG; Wang X; Ryseck RP; Fargnoli J; Henley BJ; Yang WP; Zhu J; Madireddi MT; Lawrence RM; Wong TW; Rupnow BA
Mol Cancer Res; 2011 Nov; 9(11):1551-61. PubMed ID: 21954435
[TBL] [Abstract][Full Text] [Related]
12. FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth.
Du X; Wang QR; Chan E; Merchant M; Liu J; French D; Ashkenazi A; Qing J
Cancer Res; 2012 Nov; 72(22):5843-55. PubMed ID: 23019225
[TBL] [Abstract][Full Text] [Related]
13. Regulation of stearoyl-CoA desaturase expression.
Ntambi JM; Miyazaki M; Dobrzyn A
Lipids; 2004 Nov; 39(11):1061-5. PubMed ID: 15726820
[TBL] [Abstract][Full Text] [Related]
14. Identification and experimental validation of Stearoyl-CoA desaturase is a new drug therapeutic target for osteosarcoma.
Nie J; He C; Shu Z; Liu N; Zhong Y; Long X; Liu J; Yang F; Liu Z; Huang P
Eur J Pharmacol; 2024 Jan; 963():176249. PubMed ID: 38070637
[TBL] [Abstract][Full Text] [Related]
15. Recent advances on stearoyl-Coa desaturase regulation in fatty liver diseases.
Narce M; Bellenger J; Rialland M; Bellenger S
Curr Drug Metab; 2012 Dec; 13(10):1454-63. PubMed ID: 22978399
[TBL] [Abstract][Full Text] [Related]
16. Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment.
Fanning S; Haque A; Imberdis T; Baru V; Barrasa MI; Nuber S; Termine D; Ramalingam N; Ho GPH; Noble T; Sandoe J; Lou Y; Landgraf D; Freyzon Y; Newby G; Soldner F; Terry-Kantor E; Kim TE; Hofbauer HF; Becuwe M; Jaenisch R; Pincus D; Clish CB; Walther TC; Farese RV; Srinivasan S; Welte MA; Kohlwein SD; Dettmer U; Lindquist S; Selkoe D
Mol Cell; 2019 Mar; 73(5):1001-1014.e8. PubMed ID: 30527540
[TBL] [Abstract][Full Text] [Related]
17. Regulation of stearoyl-CoA desaturase activity by the trans-10,cis-12 isomer of conjugated linoleic acid in HepG2 cells.
Choi Y; Park Y; Pariza MW; Ntambi JM
Biochem Biophys Res Commun; 2001 Jun; 284(3):689-93. PubMed ID: 11396956
[TBL] [Abstract][Full Text] [Related]
18. Design, radiosynthesis, and evaluation of radiotracers for positron emission tomography imaging of stearoyl-CoA desaturase-1.
Silvers WC; Cai H; Öz OK; Sun X
Bioorg Med Chem Lett; 2016 Feb; 26(3):924-927. PubMed ID: 26778147
[TBL] [Abstract][Full Text] [Related]
19. A novel inhibitor of stearoyl-CoA desaturase-1 attenuates hepatic lipid accumulation, liver injury and inflammation in model of nonalcoholic steatohepatitis.
Kurikawa N; Takagi T; Wakimoto S; Uto Y; Terashima H; Kono K; Ogata T; Ohsumi J
Biol Pharm Bull; 2013; 36(2):259-67. PubMed ID: 23370355
[TBL] [Abstract][Full Text] [Related]
20. [Research progress of stearoyl-CoA desaturase-1 on obesity and non-alcoholic fatty liver disease Abstract].
Chen C; Hu YY; Feng Q
Zhonghua Gan Zang Bing Za Zhi; 2018 Jul; 26(7):545-548. PubMed ID: 30317781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
